NO20042380L - Pharmaceutical preparation comprising factor VII polypeptides and factor V polypeptides - Google Patents

Pharmaceutical preparation comprising factor VII polypeptides and factor V polypeptides

Info

Publication number
NO20042380L
NO20042380L NO20042380A NO20042380A NO20042380L NO 20042380 L NO20042380 L NO 20042380L NO 20042380 A NO20042380 A NO 20042380A NO 20042380 A NO20042380 A NO 20042380A NO 20042380 L NO20042380 L NO 20042380L
Authority
NO
Norway
Prior art keywords
polypeptides
factor
pharmaceutical preparation
factor vii
vii polypeptides
Prior art date
Application number
NO20042380A
Other languages
Norwegian (no)
Inventor
Rasmus Rojkjaer
Original Assignee
Novo Nordisk Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk Healthcare Ag filed Critical Novo Nordisk Healthcare Ag
Publication of NO20042380L publication Critical patent/NO20042380L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20042380A 2001-11-09 2004-06-08 Pharmaceutical preparation comprising factor VII polypeptides and factor V polypeptides NO20042380L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101660 2001-11-09
PCT/DK2002/000736 WO2003039584A1 (en) 2001-11-09 2002-11-05 Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides

Publications (1)

Publication Number Publication Date
NO20042380L true NO20042380L (en) 2004-06-08

Family

ID=8160820

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042380A NO20042380L (en) 2001-11-09 2004-06-08 Pharmaceutical preparation comprising factor VII polypeptides and factor V polypeptides

Country Status (16)

Country Link
EP (1) EP1446149A1 (en)
JP (1) JP2005511599A (en)
KR (1) KR20050043734A (en)
CN (1) CN1596125A (en)
AU (1) AU2002340779B2 (en)
BR (1) BR0213953A (en)
CA (1) CA2464615A1 (en)
CZ (1) CZ2004543A3 (en)
HU (1) HUP0401985A3 (en)
IL (1) IL161544A0 (en)
MX (1) MXPA04004304A (en)
NO (1) NO20042380L (en)
PL (1) PL370634A1 (en)
RU (1) RU2004117534A (en)
WO (1) WO2003039584A1 (en)
ZA (1) ZA200403271B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ200240A3 (en) 1999-07-14 2003-04-16 Novo Nordisk A/S Medicament containing agonist or antagonist of tissue factor for regulating cell migration
ES2381110T3 (en) 2003-09-09 2012-05-23 Novo Nordisk Health Care Ag Coagulation Factor VII Polypeptides
BRPI0507156A (en) * 2004-02-05 2007-06-26 Novo Nordisk Healthcare Ag use of factor viia or a factor viia equivalent, parts kit and method to prevent or mitigate one or more late trauma complications, and methods to reduce the number of days a trauma patient is hospitalized after trauma to reduce the number of days a trauma patient spends in an intensive care unit after trauma, to improve lung function in a trauma patient, to reduce the risk of developing acute lung injury and / or acute respiratory distress syndrome in a patient. to reduce the risk of developing disseminated intravascular coagulation in a trauma patient, to reduce the risk of developing systemic inflammatory response syndrome in a trauma patient, to reduce the risk of developing multiple organ failure in a trauma patient , to reduce the risk of death in a trauma patient and to prevent or mitigate one or more late trauma complications.
FR2894831B1 (en) * 2005-12-16 2008-02-15 Lab Francais Du Fractionnement THROMBIN FREE BIOLOGICAL GLUE AND USE THEREOF AS MEDICAMENT.
US8461115B2 (en) 2006-03-16 2013-06-11 Stellaris Pharmaceuticals Aps Methods for local treatment with factor VII
CN105848668A (en) * 2013-11-04 2016-08-10 加利福尼亚大学董事会 Therapy for treatment or prevention of conditions associated with bleeding or hypocoagulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE200225T1 (en) * 1994-04-22 2001-04-15 Sanquin Bloedvoorziening AGENTS FOR THE TREATMENT OF DISORDERS OF THE BLOOD CLOTTING PROCESS
AU7907398A (en) * 1997-06-23 1999-01-04 Novo Nordisk A/S Use of fviia for the treatment of bleedings in patients with a normal blood clotting cascade and normal platelet function
WO1999058699A2 (en) * 1998-05-14 1999-11-18 Battelle Memorial Institute Transgenic plant-derived human blood coagulation factors

Also Published As

Publication number Publication date
PL370634A1 (en) 2005-05-30
CA2464615A1 (en) 2003-05-15
BR0213953A (en) 2004-08-31
EP1446149A1 (en) 2004-08-18
WO2003039584A1 (en) 2003-05-15
HUP0401985A3 (en) 2009-03-30
AU2002340779B2 (en) 2007-08-02
JP2005511599A (en) 2005-04-28
HUP0401985A2 (en) 2004-12-28
MXPA04004304A (en) 2004-08-11
ZA200403271B (en) 2004-11-08
KR20050043734A (en) 2005-05-11
CZ2004543A3 (en) 2004-08-18
RU2004117534A (en) 2005-05-10
IL161544A0 (en) 2004-09-27
CN1596125A (en) 2005-03-16

Similar Documents

Publication Publication Date Title
DK1417175T3 (en) SUBSTITUTED DIHYDRO-3-HALO-1H-PYRAZOL-5-CARBOXYLATES AND PREPARATION AND USE THEREOF
NO20044192L (en) 17alpha-alkyl-17beta-oxy-ostratrienes and pharmaceutical preparations
NO20033143D0 (en) Pharmaceutical preparation
NO20033556D0 (en) Pharmaceutical preparations
DK1390389T3 (en) Crypto-blocking antibodies and uses thereof
HUP0500989A2 (en) Animicrobial polypeptides and their uses
NO20033785L (en) Pharmaceutical formulation
DK200300344U1 (en) Amlodipine maleate and pharmaceutical composition containing amlodipine maleate
NO20034159D0 (en) The estrogen-gestagen combination preparation and its use
IS7089A (en) Pharmaceutical combinations of amlodipine and atorvastatin
NO20035627D0 (en) Pharmaceutical formulation
NO20025805D0 (en) Pharmaceutical preparation
NO20040235L (en) Pharmaceutical preparation comprising Factor VII polypeptides and Factor XI polypeptides
IL159872A0 (en) Gmg-2 polypeptides and their use
EP1462455A4 (en) Novel peptides and medicinal uses thereof
NO20042693L (en) Catheter preparation and applications thereof
NO20023144D0 (en) Complex comprising OCIF and polysaccharide
NO20042380L (en) Pharmaceutical preparation comprising factor VII polypeptides and factor V polypeptides
NO20042379L (en) Pharmaceutical preparation comprising factor VII polypeptides and PAI-1 polypeptides
NO20015534D0 (en) Pharmaceutical mixer
NO20021036D0 (en) Pharmaceutical preparation
DE60219418D1 (en) SILANOLLPHENOL AND NAPHTHOLE
DK200100256U3 (en) Amlodipine maleate and pharmaceutical preparations containing this
NO20041236L (en) Pharmaceutical Formulation
GB0109558D0 (en) Polypeptides and their uses

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application